|[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]|
FDA Warns of Risks with Unapproved Use of Malaria Drug Qualaquin
Thu, 08 Jul 2010 09:45:00 -0500
The U.S. Food and Drug Administration today warned that the unapproved use of the malaria drug Qualaquin (quinine sulfate) to treat night time leg cramps has resulted in serious side effects and prompted the manufacturer to develop a risk management plan aimed at educating health care professionals and patients about the potential risks.
Manage your FDA Subscriptions:
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · 10903 New Hampshire Ave MD 20993 · 800-439-1420